Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

President and CEO

Chief Medical Officer

Chief Business & Legal Officer

Chief Financial Officer

Chief Strategy & Financial Off

Chief Regulatory Officer

Chief Commercial Officer

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ÃƒÅ¸-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ÃƒÅ¸-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-04	Premium	sold	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-01	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-05	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-05	Premium	sold	Premium	Premium	Premium	President and CEO
2024-02-05	Premium	sold	Premium	Premium	Premium	Chief Business & Legal Officer
2024-01-05	Premium	sold	Premium	Premium	Premium	President and CEO
2024-01-05	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-12-06	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-11-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-11-02	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-09-05	Premium	sold	Premium	Premium	Premium	See Remarks
2023-08-10	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-02	Premium	sold	Premium	Premium	Premium	See Remarks
2023-04-03	Premium	acquired	Premium	Premium	Premium	-
2023-03-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-03-01	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-03-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-02-01	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks

BLUE - Bluebird Bio Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for BLUE